To make available locally and at a lower cost the cyclotron production of PET radiopharmaceuticals based on fluorine-18 in the existing facility with already installed medical cyclotrons, and establish a national certified training programme in radiopharmacy in order to cater for the absence of certified training in radiopharmacy in the country.